← Back to Search

Interventional for Limited English Proficiency

N/A

Recruiting

Led By Mary Pilarz, MD

Research Sponsored by Ann & Robert H Lurie Children's Hospital of Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

All patients and families admitted to the pediatric intensive care unit (PICU) whose family requires an interpreter

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial aims to compare the rates of interpreter use before and after allowing non-English speaking families to call an interpreter themselves. The study wants to determine if it is practical for families to call an interpreter

Who is the study for?

This trial is for non-English speaking families with a member in the pediatric intensive care unit (PICU) who need an interpreter to communicate with medical staff.Check my eligibility

What is being tested?

The study tests if letting families call an interpreter themselves using a tablet increases how often they use professional interpreters. It includes training on the app and surveys about its ease of use and helpfulness.See study design

What are the potential side effects?

There are no direct medical side effects from participating in this trial as it involves the use of technology for communication, not medication or clinical interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Interpreter Utilization

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionalExperimental Treatment1 Intervention

This arm will be given interpreter tablets in order to allow them to call interpreter themselves.

Group II: Pre-InterventionActive Control1 Intervention

The medical team will use standard interpreter practices with this group.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Ann & Robert H Lurie Children's Hospital of ChicagoLead Sponsor

258 Previous Clinical Trials

5,189,010 Total Patients Enrolled

Northwestern University Feinberg School of MedicineOTHER

38 Previous Clinical Trials

14,751 Total Patients Enrolled

Mary Pilarz, MDPrincipal InvestigatorAnn and Robert H. Lurie Children's Hospital of Chicago

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the overall count of participants who are signing up for this clinical study?

"Indeed, the details on clinicaltrials.gov confirm that this ongoing trial is currently in search of eligible participants. The initial posting was made on April 3rd, 2023 and the most recent update occurred on January 9th, 2024. Recruitment aims to enroll a total of 120 patients from a single designated site."

Answered by AI

Are individuals currently being enrolled in this trial?

"Indeed, the information available on clinicaltrials.gov indicates that this clinical trial is currently seeking eligible participants. The trial was initially posted on April 3rd, 2023 and underwent its most recent update on January 9th, 2024. A total of 120 patients will be enrolled in this study at a single designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Family-Initiated Interpretation in the PICU

2023. "Family-Initiated Interpretation in the PICU". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05791240.